The Medicilon peptide synthesis research team focuses closely on peptide drug research and is committed to solving the core issues that hinder the development and application of peptide drugs. Currently, the team has established capabilities in synthesizing upstream non-natural amino acid structural units, modifying peptide drugs, and conducting large-scale synthesis, thereby creating a comprehensive system for researching downstream peptide drug signal transduction pathways and mechanisms of action.
Through multidisciplinary cooperation and collaboration across chemistry, biology, medicine, pharmacy, and other fields, the team has achieved outstanding achievements in both basic and applied research.